United States · Series D startup
5 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$120Mraised across 5 rounds since 2005, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
TPG
Novo Holdings
Sevin Rosen Funds
Delphi Ventures
H.I.G. Capital
Washington Research FoundationReported by prnewswire.com
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sevin Rosen FundsWashington Research FoundationVentures WestTPGDelphi VenturesH.I.G. CapitalNovo HoldingsMissing a round, or an investor who was in one? Tell us.
Alder Biopharmaceuticals's investors include Sevin Rosen Funds, Washington Research Foundation, Ventures West, TPG and Delphi Ventures, and 2 more on record.
Alder Biopharmaceuticals has raised $120M across 5 rounds since 2005.
Alder Biopharmaceuticals's most recent round was a Series D of $38M in Apr 2012.
Alder Biopharmaceuticals's largest round on record is $40M (Series C), in Dec 2007.
Alder Biopharmaceuticals's first round on record, in Jul 2005, was backed by Sevin Rosen Funds, Washington Research Foundation and Ventures West.
Alder Biopharmaceuticals's latest named round is a Series D, in Apr 2012.
Alder Biopharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·